Roscigno, M. (2012). Reply to Alison J. Birtle, Rebecca Lewis, Emma hall's letter to the editor on behalf of the POUT trial management group re: Marco Roscigno, Maurizio Brausi, Axel Heidenreich, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol 2011;60:776-83. EUROPEAN UROLOGY, 61(3), 17-17 [10.1016/j.eururo.2011.11.061].

Reply to Alison J. Birtle, Rebecca Lewis, Emma hall's letter to the editor on behalf of the POUT trial management group re: Marco Roscigno, Maurizio Brausi, Axel Heidenreich, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol 2011;60:776-83

Roscigno M
2012

Lettera in rivista
antineoplastic agent
English
2012
61
3
17
17
reserved
Roscigno, M. (2012). Reply to Alison J. Birtle, Rebecca Lewis, Emma hall's letter to the editor on behalf of the POUT trial management group re: Marco Roscigno, Maurizio Brausi, Axel Heidenreich, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol 2011;60:776-83. EUROPEAN UROLOGY, 61(3), 17-17 [10.1016/j.eururo.2011.11.061].
File in questo prodotto:
File Dimensione Formato  
Roscigno-2012-European Urology-VoR.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 84.77 kB
Formato Adobe PDF
84.77 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/612962
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
Social impact